Fresenius Medical Care (FME), the world’s main supplier of services for people with renal ailments, has taken the Zero Well being Gaps Pledge on the World Financial Discussion board in Davos, Switzerland.
The Zero Well being Gaps Pledge is a part of the International Well being Fairness Community (GHEN), which brings collectively key stakeholders from the private and non-private sectors to advance a collective imaginative and prescient of Zero Well being Gaps, according to the UN Sustainable Improvement Objectives. In whole, 36 firms from eight international locations dedicated to signal the first-in-kind world pledge. By taking the pledge, Fresenius Medical Care is declaring its dedication to significant motion and collaboration towards well being fairness.
“We imagine that entry to equitable and high-quality well being care is a basic human proper, and we’re dedicated to working with world leaders and organizations to enhance the lives of tens of millions of individuals all through the world,” stated Helen Giza, CEO of Fresenius Medical Care. “We may even look inward and obtain clear, actionable steps to make our processes economically and environmentally sustainable, whereas rising entry to the care we offer within the world communities we serve.”
The distinction in common life expectancy at delivery between high- and low-income international locations is obvious at 78 and 64 years respectively. International local weather and well being crises, together with the COVID-19 pandemic, have heightened each the severity of those inequities and the potential penalties of inaction. The Zero Well being Gaps Pledge is a direct response to the rising well being disparities throughout the globe.
Fresenius Medical Care has taken plenty of actions to deal with well being fairness. The corporate’s Well being Fairness Dashboard offers vital demographic and regional information to determine attainable inequities in key affected person outcomes. The purpose is to tailor interventions to people in several places to assist guarantee there aren’t any care supply gaps.
“Round 3.8 million sufferers worldwide commonly endure dialysis therapy. Fresenius Medical Care is passionate in regards to the significance of closing the gaps in well being fairness,” stated Franklin W. Maddux, MD, International Chief Medical Officer. “We’re excited to assist prepared the ground for the worldwide well being care neighborhood by taking the Zero Well being Gaps Pledge and sit up for tackling this important problem head on.”
Nwamaka (Amaka) Eneanya, MD, Head of Technique and Operations for the International Medical Workplace, will lead the corporate’s world well being fairness technique together with its efforts to satisfy the Zero Well being Gaps Pledge. She is going to work with Mignon Early, Vice President of Variety, Fairness, and Inclusion, to make sure strategic initiatives are developed within the context of Fresenius Medical Care’s numerous worker base.
Click on right here to learn the whole “Zero Well being Gaps Pledge” together with its ten key commitments, and click on right here to study extra in regards to the International Well being Fairness Community.
Fresenius Medical Care is the world’s main supplier of services for people with renal ailments of which round 3.8 million sufferers worldwide commonly endure dialysis therapy. By means of its community of 4,153 dialysis clinics, Fresenius Medical Care offers dialysis remedies for about 345,000 sufferers across the globe. Fresenius Medical Care can be the main supplier of dialysis merchandise reminiscent of dialysis machines or dialyzers. Together with its core enterprise, the Renal Care Continuum, the Firm focuses on increasing in complementary areas and within the area of important care. Fresenius Medical Care is listed on the Frankfurt Inventory Alternate (FME) and on the New York Inventory Alternate (FMS).
For extra data go to the Firm’s web site at www.freseniusmedicalcare.com.
Disclaimer:
This launch accommodates forward-looking statements which might be topic to varied dangers and uncertainties. Precise outcomes might differ materially from these described in these forward-looking statements attributable to varied elements, together with, however not restricted to, adjustments in enterprise, financial and aggressive situations, authorized adjustments, regulatory approvals, impacts associated to the COVID-19 pandemic outcomes of scientific research, international change price fluctuations, uncertainties in litigation or investigative proceedings, and the provision of financing. These and different dangers and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA’s reviews filed with the U.S. Securities and Alternate Fee. Fresenius Medical Care AG & Co. KGaA doesn’t undertake any duty to replace the forward-looking statements on this launch.
Media contact
Martin Kunze
T +49 6172 608-2115
[email protected]
Media contact (North America)
Christopher Loh
[email protected]
Contact for analysts and buyers
Dr. Dominik Heger
T +49 6172 609-2601
[email protected]
www.freseniusmedicalcare.com
SOURCE Fresenius Medical Care Holdings, Inc.
